Last Update Time:
13-Mar-2025 16:00:00
ISIN:
INE019J01013
Sector:
Healthcare
Symbol:
SASTASUNDR
Sastasundar Ventures Limited
₹238.00
₹1.31
(0.55%)
▲
Prev. Close
₹236.69
Open
₹243.00
Close
₹241.68
Range
₹226.10 - ₹249.90
High
₹246.60
Low
₹236.66
Ind. Close
₹0.00
VWAP
₹242.66
The current stock price of Sastasundar Ventures Limited is ₹238.00, with a target price range between ₹226.10 and ₹249.90. The stock has experienced a price change of ₹1.31 (0.55%), reflecting recent market volatility.
Today's opening price was ₹243.00, while the previous close stood at ₹236.69.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Sastasundar Ventures Limited Price Chart
Sastasundar Ventures Limited Pre Open Market Overview: 13-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 243
- Previous Close Price: 236.69
- Change: 6.31%
- Total Traded Volume: 373
- Total Buy Quantity: 15,624
- Total Sell Quantity: 1,311
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 232.50 | 25.00 | 0.00 |
| 233.10 | 1,000.00 | 0.00 |
| 234.10 | 1,000.00 | 0.00 |
| 234.66 | 50.00 | 0.00 |
| 243.00 | 427.00 | 0.00 |
| 243.15 | 0.00 | 33.00 |
| 243.30 | 0.00 | 20.00 |
| 243.60 | 0.00 | 1.00 |
| 245.65 | 0.00 | 20.00 |
| 249.95 | 0.00 | 250.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 15624
Total Sell Quantity: 1311
Shareholding Patterns of Sastasundar Ventures Limited
Key Trade Statistics of Sastasundar Ventures Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.66 |
| Traded Value (₹ Cr.) | 1.60 |
| Total Market Cap (₹ Cr.) | 757.09 |
| Free Float Market Cap (₹ Cr.) | 186.86 |
| Impact cost | 0.35 |
| Quantity Traded | 65,841.00 |
| Deliverable Quantity | 49,722.00 |
| % of Quantity to Traded | 75.52 |
| Security VaR | 19 |
| Index VaR | N/A |
| VaR Margin | 19 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 22.5 |
| Face Value | 10 |
Key Price Statistics of Sastasundar Ventures Limited
The 52-week high for Sastasundar Ventures Limited was ₹381.70, recorded on 12-Dec-2024. On the other hand, the 52-week low stands at ₹205.00, with the lowest value recorded on 03-Mar-2025.
The upper band for trading is ₹284.02, and the lower band is ₹189.35. The price band is 20%.
The stock's daily volatility stands at 2.90, while the annualized volatility is 55.40. The tick size for trading is ₹0.01.
| Price Information | Details |
|---|---|
| 52 Week High (12-Dec-2024) | 381.70 |
| 52 Week Low (03-Mar-2025) | 205.00 |
| Upper Band | 284.02 |
| Lower Band | 189.35 |
| Price Band (%) | 20 |
| Daily Volatility | 2.90 |
| Annualised Volatility | 55.40 |
| Tick Size | 0.01 |
Key Securities Statistics of Sastasundar Ventures Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 05-Oct-2010 |
| Adjusted P/E | 8.99 |
| Symbol P/E | 0 |
| Index | NA |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Basic Industry | Healthcare Service Provider |
Security Status of Sastasundar Ventures Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Sastasundar Ventures Limited
| Subject | Date |
|---|---|
| Investor Presentation | 19-Feb-2025 |
| Copy of Newspaper Publication | 15-Feb-2025 |
| Sale or disposal-XBRL | 15-Feb-2025 |
| Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | 15-Feb-2025 |
| Disclosure of material issue | 14-Feb-2025 |
| Integrated Filing- Financial | 14-Feb-2025 |
| Appointment | 14-Feb-2025 |
| Resignation | 14-Feb-2025 |
Corporate Actions of Sastasundar Ventures Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Annual General Meeting | 23-Sep-2024 |
| 10 | Annual General Meeting | 22-Sep-2023 |
| 10 | Annual General Meeting | 21-Sep-2022 |
| 10 | Annual General Meeting | 20-Sep-2021 |
| 10 | Annual General Meeting | 03-Sep-2020 |
| 10 | Annual General Meeting | 20-Sep-2019 |
| 10 | Annual General Meeting | 03-Aug-2018 |
| 10 | Annual General Meeting | 28-Jul-2017 |
| 10 | Annual General Meeting | 16-Sep-2016 |
| 10 | Annual General Meeting | 16-Sep-2015 |
| 10 | Annual General Meeting | 04-Aug-2014 |
| 10 | Annual General Meeting | 02-Aug-2013 |
| 10 | Annual General Meeting / Dividend Rs 1.00 Per Share | 23-Jul-2012 |
| 10 | Annual General Meeting And Dividend Re.1/- Per Share | 25-Jul-2011 |
Board Meetings of Sastasundar Ventures Limited
Financial Results of Sastasundar Ventures Limited
Company Directory of Sastasundar Ventures Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.microsec.in | Head Office/ Corporate Office | Azimganj House, 2nd Floor, 7, Camac Street, |
KOLKATA |
| www.microsec.in | Registered Office | Azimganj House, 2nd Floor, 7 Abanindra Nath Thakur Sarani (Formerly Camac St) |
KOLKATA |
| www.microsec.in | Transfer Agent | Link Intime India Pvt. Ltd. 59C, Chowringhee Road, 3rd Floor, |
KOLKATA |
Insider Trading of Sastasundar Ventures Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Luv Kush Projects Limited | 10926281 | Buy |
| 7(2) | Mahuya De | 1743057 | Sell |
| 7(2) | Luv Kush Projects Limited | 1550936 | Buy |
| 7(2) | Ravi Kant Sharma jointly with Luv Kush Projects Limited as Trustee of Microsec Vision Trust One | 100836500 | Sell |
| 7(2) | Luv Kush Projects Limited | 101132647 | Buy |
| 7(2) | Ravi Kant Sharma jointly with Luv Kush Projects Limited as Trustee of Microsec Vision Trust One | 153285966 | Sell |
| 7(2) | Ravi Kant Sharma | 153737059 | Buy |
| 7(2) | Manisha Sethia | 765681 | Sell |
| 7(2) | SANJAY AGARWAL | 290168 | Sell |
| 7(2) | Mahuya De | 891914 | Sell |
| 7(2) | RAMESH KUMAR SHARMA | 479118 | Sell |
| 7(2) | RAMESH KUMAR SHARMA | 968536 | Sell |
| 7(2) | Manisha Sethia | 0 | Buy |
| 7(2) | Atul Jain | 0 | Buy |
| 7(2) | SANJAY AGARWAL | 0 | Buy |
| 7(2) | VINAY KHAITAN | 0 | Buy |
| 7(2) | Pankaj Sharma | 0 | Buy |
| 7(2) | Mahesh Kumar Singhi | 0 | Buy |
| 7(2) | ABHISHEK SINGHI | 0 | Sell |
| 7(2) | Luv Kush Projects Limited | 16921998 | Buy |
Annual Reports of Sastasundar Ventures Limited
Investor Complaints of Sastasundar Ventures Limited
Event Calendar of Sastasundar Ventures Limited
| Purpose | Details |
|---|---|
| Results/Others | Inter alia, To consider various business, including consideration and approval of the Unaudited Financial Results of the Company for the Third Quarter and nine months ended December 31, 2012. |
| Results | Inter-alia to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2013. |
| Results | To consider inter-alia the Un-Audited standalone and consolidated Financial Results of the Company for the First Quarter ended on June 30, 2013. |
| Results | To consider inter-alia the Un-Audited standalone and consolidated Financial Results of the Company for the Second Quarter ended on September 30, 2013. |
| Results | To consider inter-alia the Un-Audited standalone and consolidated Financial Results of the Company for the Third Quarter ended on December 31, 2013. |
| Results | inter-alia to consider and approve the Audited Financial Results of the Company for the financial year ended on March 31, 2014. |
| Results | Inter alia, to consider the Un-Audited standalone and consolidated Financial Results of the Company for the First Quarter ended on June 30, 2014. Further, Pursuant to the provisions of Clause 36 of the Listing Agreement with the Stock Exchanges and in view of the declaration of the Unaudited Financial Results for the quarter ended June 30, 2014, the Trading Window under the Company's Code of Conduct for Prevention of Insider Trading" shall remain closed for dealing in shares of the Company for the Designated Employees defined in the code from August 4, 2014 to August 14, 2014 (both days inclusive). |
| Results | To consider Inter alia the Un-Audited standalone and consolidated Financial Results of the Company for the Quarter and half year ended on September 30, 2014. |
| Results | To consider inter-alia the Un-Audited standalone and consolidated Financial Results of the Company for the Quarter ended on December 31, 2014. |
| Results | Inter-alia, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the fourth quarter and financial year ended March 31, 2015. |
| Results | Inter-alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2015. |
| Results | inter-alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the second quarter ended September 30, 2015. |
| Results | inter-alia, to consider and approve the Unaudited Standalone and Consolidated financial Results of the Company for the quarter ended December 31, 2015. |
| Demerger | 1. the proposed demerger of the undertaking consisting of certain assets or undertakings such as investment in shares, securities and properties (Investment Undertaking) of Microsec Capital Limited (''MCap"), a wholly owned subsidiary of the Company and also of Microsec Commerze Limited ("MCL"), a wholly owned subsidiary of MCap, wherein the aforesaid Investment Undertakings of both MCap and MCL shall be demerged into one or more separate company (ies). 2. the draft Share Purchase Agreement ("SPA") for sale of 100% shareholding in the demerged Company i.e. Microsec Capital Limited. |
| Results | Inter-alia, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2016. |
| Results | Inter-alia, to consider and approve the Unaudited Standalone Financial Results of the Company for the quarter ended June 30, 2016. Further, for the purpose of declaration of the Unaudited Financial Results for the quarter ended 30th June, 2016 the Trading Window under the Company's "Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders" shall remain closed for dealing in shares of the Company by the Directors, Designated Persons and their immediate relatives defined in the code from July 27, 2016 to August 7, 2016 (both days inclusive). |
| Results | inter-alia, to consider and approve the Unaudited Standalone Financial Results of the Company for the quarter and half year ended 30th September, 2016. |
| Others | to inter-alia consider, discuss and approve the following matters: 1. Approve the Postal Ballot Notice. 2. The proposed merger of certain subsidiary companies with the Company. |
| Results | inter-alia, to consider and approve the Unaudited Standalone Financial Results of the Company for the quarter ended December 31, 2016. Further, for the purpose of declaration of the Unaudited Financial Results for the quarter ended December 31, 2016 the Trading Window under the Company's "Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders" shall remain closed for dealing in shares of the Company by the Directors, Designated Persons and their immediate relatives defined in the code from February 03, 2017 to February 16, 2017 (both days inclusive). |
| Results | inter-alia, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2017. Further, for the purpose of declaration of the Audited Financial Results for the quarter and year ended 31st March, 2017 the Trading Window under the Company's "Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders" shall remain closed for dealing in shares of the Company by the Directors, Designated Persons and their immediate relatives defined in the code from 18th May, 2017 to 28th May, 2017 (both days inclusive). |
| Results | Inter-alia, to consider and approve the Un Audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2017. |
| Results | Inter-alia, to consider and approve the Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2017. |
| Results | inter-alia, to consider and approve the Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2017. |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2018 |
| Financial Results | To consider and approve the unaudited standalone and consolidated financial results for the quarter ended Jun 30, 2018. |
| Financial Results | To consider and approve the Unaudited Standalone and Consolidated financial results for the quarter and half year ended September 30, 2018. |
| Financial Results | To consider and approve the unaudited financial results for the period ended December 31, 2018 |
| Financial Results | To consider and approve theￂﾠAudited Standalone and Consolidated Financial Results of the Company for the quarter and financial yearￂﾠended March 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
| Financial Results | To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December, 2019. |
| Financial Results | To consider and approveￂﾠthe Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended 31st March, 2020. |
| Financial Results | To consider and approve the unaudited financial results for the period ended Jun 30, 2020 |
| Financial Results | To consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2020. |
| Financial Results | To consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2020. |
| Financial Results | To consider and approve theￂﾠAudited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended 31st March, 2021. |
| Financial Results | To consider and approve the unaudited financial results for the period ended Jun 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results | To consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2021. |
| Financial results | Sastasundar Ventures Limited has informed the Exchange about Board Meeting to be held on 30-May-2022 to consider financial statements for the period ended March 2022 |
| Financial results | Sastasundar Ventures Limited has informed the Exchange about Board Meeting to be held on 13-Aug-2022 to consider financial statements for the period ended June 2022 |
| Financial results | Sastasundar Ventures Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2022 to consider financial statements for the period ended September 2022 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2022 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2023 |
| Other business matters | Intimation of Board Meeting to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended 31st March, 2023. |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results | To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2023. |
| Financial Results | To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December, 2023. |
| Financial Results | To consider and approve the Audited Standalone and Consolidated financial results for the quarter and financial year ended March 31, 2024 |
| Financial Results | To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30th June, 2024. |
| Financial Results | To consider and approve the Unaudited Standalone and Consolidated Financial Results ofor the quarter and half year ended September 30, 2024. |
| Financial Results | To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2024. |
Share Transfers of Sastasundar Ventures Limited
Voting Results of Sastasundar Ventures Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 30-SEP-2024 | AGM | To receive, consider and adopt the Audited Financial Statements (both Standalone and Consolidated) of the Company for the financial year ended 31st March, 2024 together with Report of the Board of Directors and Auditors thereon. |
| 30-SEP-2024 | AGM | To appoint a Director in place of Mrs. Abha Mittal (DIN: 00519777) who retires by rotation, and being eligible offers herself for re-appointment. |
| 25-MAR-2024 | Postal Ballot | Approval of Material Related Party Transaction(s) between Sastasundar Healthbuddy Limited, subsidiary of Sastasundar Ventures Limited and Retailer Shakti Supply Chain Private Limited, step down subsidiary of Sastasundar Ventures Limited |
| 30-JAN-2024 | Postal Ballot | Re-Appointment of Dr. Jayanta Nath Mukhopadhyaya (DIN - 09015844) as an Independent Director of the Company for the second term of 5 (five) consecutive years. |
| 30-JAN-2024 | Postal Ballot | Appointment of Mrs. Anjana Dikshit (DIN - 10377490) as an Independent Director of the Company for a term of 3 (three) consecutive years. |
| 29-SEP-2023 | AGM | To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended 31st March, 2023 (both Standalone and Consolidated), together with Report of the Board of Directors and Auditors thereon. |
| 29-SEP-2023 | AGM | Re-appointment of Mr. Banwari Lal Mittal (DIN: 00365809) as the Managing Director & CEO of the Company for a further period of five years with effect from 1st July, 2023. |
| 29-SEP-2023 | AGM | To appoint a Director in place of Mr. Ravi Kant Sharma (DIN: 00364066) who retires by rotation, and being eligible offers himself for re-appointment. |
| 29-SEP-2022 | AGM | To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended 31st March, 2022 (both Standalone and Consolidated), together with Report of the Board of Directors and Auditors thereon. |
| 29-SEP-2022 | AGM | Approval of Material Related Party Transaction(s) between Sastasundar Healthbuddy Limited, subsidiary of Sastasundar Ventures Limited and Retailer Shakti Supply Chain Private Limited, step down subsidiary of Sastasundar Ventures Limited. |
| 29-SEP-2022 | AGM | Appointment of M/s. J K V S & CO, Chartered Accountants (FRN 318086E) as Statutory Auditors of the Company for a period of 5 (five) consecutive years. |
| 29-SEP-2022 | AGM | To appoint a Director in place of Mrs. Abha Mittal (DIN: 00519777) who retires by rotation and being eligible, offers herself for re-appointment. |
| 08-FEB-2022 | Postal Ballot | Appointment of JKVS & Co., Chartered Accountants, as Statutory Auditors of the Company to fill the casual vacancy caused by the resignation of Singhi & Co., Chartered Accountants. |
| 08-FEB-2022 | Postal Ballot | Desubsidiarisation of Sastasundar Marketplace Limited, a step down subsidiary of the Company. |
| 28-SEP-2021 | AGM | To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended 31st March, 2021 (both Standalone and Consolidated), together with Report of the Board of Directors and Auditors thereon. |
| 28-SEP-2021 | AGM | Appointment of Dr. Jayanta Nath Mukhopadhyaya as an Independent Non-Executive Director for a period of 3 (three) years from 22nd June, 2021. |
| 28-SEP-2021 | AGM | Appointment of Mrs. Rupanjana De as an Independent Non-Executive Director for a period of 5 (five) years from 15th September, 2020. |
| 28-SEP-2021 | AGM | To appoint a Director in place of Mr. Ravi Kant Sharma (DIN: 00364066) who retires by rotation and being eligible, offers himself for re-appointment. |
| 11-SEP-2020 | AGM | Consider and adopt the Audited Financial Statement (both Standalone and Consolidated), Report of the Board of Directors and Auditors for the financial year ended 31st March, 2020 |
| 11-SEP-2020 | AGM | To appoint a Director in place of Mrs. Abha Mittal (DIN: 00519777) who retires by rotation and being eligible, offers herself for re-appointment |
FAQs on Sastasundar Ventures Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.